Biomarker Research Alliance for Diagnosing Heart Disease in the Ageing European Population

akronüüm: BestAgeing
algus: 2013-02-01
lõpp: 2017-01-31
 
programm: FP7 - Euroopa Liidu 7. raamprogramm
alaprogramm: HEALTH - Tervis
instrument: CP-IP - Suuremahulised integreeritud projektid
projektikonkurss: FP7-HEALTH-2012-INNOVATION-1
projekti number: 306031
kestus kuudes: 36
partnerite arv: 19
 
lühikokkuvõte: The ageing of the European population represents a rapidly rising social and economic challenge. Especially cardiovascular morbidity increases with age, but unfortunately, elderly patients are often difficult to diagnose due to confounding factors, leading to uncertainties in clinical decision making with huge impact on patients’ outcomes. Hence, there is an unmet need for novel biomarkers for more accurate diagnosis, risk assessment, and clinical outcome prediction for both acute and chronic cardiovascular diseases in the elderly. The BestAgeing consortium aims to improve this lack of diagnostic capabilities by developing and validating innovative omics-based biomarkers particularly for elderly patients – supporting healthy ageing in Europe. Our study design addresses the most frequent and severe cardiovascular diseases of elderly patients by incorporating the appropriate disease cohorts and biomaterials from European populations. We aim to develop new omics-assays to diagnose cardiovascular disease, estimate risk, and monitor the response to treatment in elderly. This is envisaged to enable a more stratified and economic delivery of medicine. We expect that BestAgeing will generate novel European medical technologies that can improve the efficacy and efficiency of our care for elderly patients, which will also impact on socioeconomic wealth in Europe.
partneri jrk nr ja roll partneri nimi riik kontaktisik koduleht
1 koordinaator UNIVERSITAETSKLINIKUM HEIDELBERG DE Hugo A. Katus http://www.klinikum.uni-heidelberg.de
2 partner FEBIT BIOMED GMBH DE Markus Beier http://www.febit.de
3 partner UNIVERSITAET DES SAARLANDES DE Andreas Keller http://www.uni-saarland.de
4 partner Tartu Ülikool EE Andres Metspalu http://www.ut.ee
5 partner UNIVERSITA DEGLI STUDI DI PADOVA IT Mario Plebani http://www.unipd.it
6 partner metanomics GmbH DE Jens Fuhrmann http://www.metanomics.de
7 partner UPPSALA UNIVERSITET SE Bertil Lindahl http://www.uu.se
8 partner JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN DE Stefanie Dimmeler http://www.uni-frankfurt.de
9 partner INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) FR SYLVIANE INOCENCIO http://www.inserm.fr
10 partner Academisch Medisch Centrum bij de Universiteit van Amsterdam NL Yigal Martin Pinto http://www.amc.nl
11 partner ACS BIOMARKER BV NL Heico Breek http://www.acsbiomarker.com
12 partner Health in Code SL ES Lorenzo Monserrat Iglesias http://www.healthincode.com
13 partner SIEMENS AG DE Emil Wirsz http://www.siemens.com
14 partner UNIVERSITA CATTOLICA DEL SACRO CUORE IT Luigi Marzio Biasucci http://www.unicattolica.it
15 partner SERVICIO MADRILENO DE SALUD ES Francisco Fernandez-Aviles http://cort.as/10Yf
16 partner Multiplicom NV BE Jurgen Del-Favero http://www.multiplicom.com
17 partner National Scientific Center "Institute of Cardiology" UA Alexander Parkhomenko
18 partner NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS EL GERASIMOS FILIPPATOS http://www.elke.uoa.gr
19 partner A.C.O. San Filippo Neri IT Massimo Santini